Skip to content
10-Q

Quarterly Report

Oragenics, Inc. OGEN

0001493152-25-021257

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 6, 2025 4.17M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.56M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.46M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 217.6K sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 71.21K sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$6.41M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$6.58M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $11.4M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $864.84K
Stockholders Equity Q3 2025 · Sep 30, 2025 $9.83M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$2.13M
Stockholders Equity Q3 2025 · Mar 31, 2025 $137.69K
Stockholders Equity Q3 2025 · Dec 31, 2024 −$211.89K
Stockholders Equity Q3 2025 · Sep 30, 2024 $3.08M
Stockholders Equity Q3 2025 · Jun 30, 2024 $1.33M
Stockholders Equity Q3 2025 · Mar 31, 2024 $2.63M
Stockholders Equity Q3 2025 · Dec 31, 2023 $3.17M
Total Liabilities Q3 2025 · Sep 30, 2025 $2.87M
Total Liabilities Q3 2025 · Dec 31, 2024 $1.68M
Current Assets Q3 2025 · Sep 30, 2025 $12.71M
Current Assets Q3 2025 · Dec 31, 2024 $1.47M
Total Assets Q3 2025 · Sep 30, 2025 $12.71M
Total Assets Q3 2025 · Dec 31, 2024 $1.47M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.96
Eps Diluted Q3 2025 · Sep 30, 2025 −$5.16
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$11.32
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$101.37
Eps Basic Q3 2025 · Sep 30, 2025 −$1.96
Eps Basic Q3 2025 · Sep 30, 2025 −$5.16
Eps Basic restated Q3 2025 · Sep 30, 2024 −$11.32
Eps Basic restated Q3 2025 · Sep 30, 2024 −$101.37
Rd Expense Q3 2025 · Sep 30, 2025 $930.89K
Rd Expense Q3 2025 · Sep 30, 2025 $1.72M
Rd Expense Q3 2025 · Sep 30, 2024 $879.04K
Rd Expense Q3 2025 · Sep 30, 2024 $2.45M
Net Income Q3 2025 · Sep 30, 2025 −$3.07M
Net Income Q3 2025 · Sep 30, 2025 −$7.56M
Net Income Q3 2025 · Jun 30, 2025 −$2.27M
Net Income Q3 2025 · Mar 31, 2025 −$2.22M
Net Income Q3 2025 · Sep 30, 2024 −$2.46M
Net Income Q3 2025 · Sep 30, 2024 −$7.22M
Net Income Q3 2025 · Jun 30, 2024 −$2.31M
Net Income Q3 2025 · Mar 31, 2024 −$2.45M
Operating Income Q3 2025 · Sep 30, 2025 −$3.12M
Operating Income Q3 2025 · Sep 30, 2025 −$6.86M
Operating Income Q3 2025 · Sep 30, 2024 −$2.44M
Operating Income Q3 2025 · Sep 30, 2024 −$7.2M